febuxostat has been researched along with nitrites in 2 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (nitrites) | Trials (nitrites) | Recent Studies (post-2010) (nitrites) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 19,921 | 501 | 6,075 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlström, M; Hezel, M; Holmdahl, R; Lundberg, JO; Montenegro, MF; Peleli, M; Persson, EG; Weitzberg, E; Zhong, J; Zollbrecht, C | 1 |
| Amaral, JH; Castro, MM; Conde-Tella, SO; Gerlach, RF; Guimarães, DA; Pinheiro, LC; Rizzi, E; Tanus-Santos, JE | 1 |
2 other study(ies) available for febuxostat and nitrites
| Article | Year |
|---|---|
Enhanced XOR activity in eNOS-deficient mice: Effects on the nitrate-nitrite-NO pathway and ROS homeostasis.
Topics: Animals; Blood Pressure; Enzyme Inhibitors; Febuxostat; Gene Expression Regulation; Male; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Oxidation-Reduction; Signal Transduction; Superoxides; Xanthine Dehydrogenase | 2016 |
Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects.
Topics: Animals; Antihypertensive Agents; Antioxidants; Aorta; Blood Pressure; Disease Models, Animal; Febuxostat; Gene Expression Regulation; Humans; Hypertension, Renovascular; Matrix Metalloproteinase 2; Muscle, Smooth, Vascular; Nitric Oxide; Nitrites; Oxidative Stress; Rats; Reactive Oxygen Species; Vascular Remodeling; Xanthine Oxidase | 2019 |